NMTC Key Statistics, Chart & Performance
The current stock price of NMTC is 0.636 USD. In the past month the price decreased by -22.01%. In the past year, price decreased by -6.61%.
NMTC Latest News, Press Relases and Analysis
NMTC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 58.07B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.82B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.30B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B |
Related stock screener links
About NMTC
Company Profile
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 17 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Company Info
NEUROONE MEDICAL TECHNOLOGIE
7599 Anagram Dr
Eden Prairie MINNESOTA US
Employees: 17
Phone: 19524261383
NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ
What does NMTC do?
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 17 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
What is the current price of NMTC stock?
The current stock price of NMTC is 0.636 USD. The price increased by 5.82% in the last trading session.
Does NMTC stock pay dividends?
NMTC does not pay a dividend.
How is the ChartMill rating for NEUROONE MEDICAL TECHNOLOGIE?
NMTC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for NMTC stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
What is the Short Interest ratio of NEUROONE MEDICAL TECHNOLOGIE (NMTC) stock?
The outstanding short interest for NEUROONE MEDICAL TECHNOLOGIE (NMTC) is 0.11% of its float.
NMTC Technical Analysis
NMTC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NMTC. NMTC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NMTC Financial Highlights
Over the last trailing twelve months NMTC reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 67.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -49.33% | ||
| ROE | -65.26% | ||
| Debt/Equity | 0.13 |
NMTC Forecast & Estimates
8 analysts have analysed NMTC and the average price target is 2.27 USD. This implies a price increase of 256.84% is expected in the next year compared to the current price of 0.636.
For the next year, analysts expect an EPS growth of 72.62% and a revenue growth 27.11% for NMTC